Table 1.

Patient characteristics n=298

Characteristic	N (%)
Age, y, median	59
Range	8–84
Sex
Female	123 (41%)
Male	175 (59%)
Primary site of malignancy
Liver	61 (20%)
Biliary tract	36 (12%)
Appendix	24 (8%)
Breast	22 (7%)
Colorectal	13 (4%)
Pancreas	52 (17%)
Lung	16 (6%)
Other	74 (26%)
Patients with alterations detected	240 (80%)
Platelets >198	143 (47 %)
WBC >5.9	139 (46%)
HGB >11.9	141 (47 %)
Albumin <3.5	50 (16%)
ECOG >1	20 (7%)
Number of prior therapies >4	59 (20%)
History of Thromboembolism	31 (10%)
History of radiation	123 (41%)
Liver metastasis	76 (25%)
Number of metastasis >2	51 (17%)
Number of non-visceral metastasis >0	123 (41%)
Number of visceral metastasis >0	181 (60%)